YungShin Global Holding Corporation (TPE:3705)

Market Cap	15.50B
Revenue (ttm)	7.82B
Net Income (ttm)	1.03B
Shares Out	266.36M
EPS (ttm)	3.86
PE Ratio	15.06
Forward PE	n/a
Dividend	2.30 (4.08%)
Ex-Dividend Date	Jun 24, 2025

Volume	1,570,670
Average Volume	767,701
Open	56.80
Previous Close	56.40
Day's Range	56.60 - 58.50
52-Week Range	47.30 - 63.30
Beta	0.07
RSI	69.62
Earnings Date	Mar 28, 2025

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. The company is also involved in trade, investment, and other related businesses; import and export trading; and sale of medicine. It has operations in Taiwan, the United States, Mainland China, and Japan. The company was incorporated in 2011 and is headquartered in Taipei City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2023, YungShin Global Holding's revenue was 7.03 billion, a decrease of -3.88% compared to the previous year's 7.31 billion. Earnings were 827.30 million, a decrease of -1.40%.